Breathing Labs
Home
How To Start
Products
Breathing+ Package
Toys Package
Q&A
Login

Covid19

6Jan

Remdesivir | Horizonscan geneesmiddelen

Posted by: admin Categories: Covid19
Comments Off on Remdesivir | Horizonscan geneesmiddelen

Remdesivir | Horizonscan geneesmiddelen www.horizonscan.nl gebruikt cookies om het gebruik van de website te analyseren en het gebruiksgemak te verbeteren. Lees meer over cookies op www.rijkshuisstijl.nlSluiten Extended indication Extension of indication to include adults who do not require invasive mechanical ventilation at start of treatment. • In adolescents (aged 12 to less than 18 years […]

Read more
6Jan

Monoclonal Antibody Treatment of Breakthrough COVID-19 in Fully Vaccinated Individuals with High-Risk Comorbidities

Posted by: admin Categories: Covid19
Comments Off on Monoclonal Antibody Treatment of Breakthrough COVID-19 in Fully Vaccinated Individuals with High-Risk Comorbidities

Retrospective 1,395 vaccinated COVID-19 cases, showing significantly lower hospitalization and oxygen supplementation with monoclonal antibody treatment, primarily casirivimab-imdevimab. Hospitalization was significantly associated with comorbidities. risk of ICU admission, 88.9% lower, RR 0.11, p = 0.16, treatment 0 of 527 (0.0%), control 5 of 868 (0.6%), NNT 174, relative risk is not 0 because of continuity […]

Read more
5Jan

A World Divided & Serious Questions

Posted by: admin Categories: Covid19
Comments Off on A World Divided & Serious Questions

Remdesivir, the first COVID-19 drug to be approved by the U.S. Food and Drug Administration (FDA), was once hailed as the life-saving drug for hospitalized patients with severe COVID-19 infection. Despite emerging studies indicating it is not effective for inpatient treatment, and a declaration by the World Health Organization (WHO) that remdesivir does not reduce […]

Read more
4Jan

7.71L teenagers get COVID jab on 1st day drive, highest among states

Posted by: admin Categories: Covid19
Comments Off on 7.71L teenagers get COVID jab on 1st day drive, highest among states

Bhopal (Madhya Pradesh): The state has administered the highest number of doses of vaccine on the first day of anti-Covid inoculation drive for 15-18 age group, with 7.71 lakh teenagers getting their first dose, the state government said on Tuesday. The state government has set up 8,667 vaccination centers for teenagers in all the 52 […]

Read more
3Jan

Group protests outside Windsor Regional Hospital

Posted by: admin Categories: Covid19
Comments Off on Group protests outside Windsor Regional Hospital

Windsor, Ont. – Protesters against what they call “medical tyranny” gathered Monday afternoon outside of Windsor Regional Hospital’s Met Campus. The group, in support of the Canadian COVID Alliance, believes that the hospital has over-stepped patient’s rights with respect to power of attorney and the right of an individual to refuse certain types […]

Read more
3Jan

Erleada and Veklury Interactions Checker

Posted by: admin Categories: Covid19
Comments Off on Erleada and Veklury Interactions Checker

This report displays the potential drug interactions for the following 2 drugs: Erleada (apalutamide) Veklury (remdesivir) Edit list (add/remove drugs) Interactions between your drugs There is some concern that apalutamide may reduce the blood levels of remdesivir, which may make the medication less effective in treating viral infections such as COVID-19. Talk to your doctor […]

Read more
2Jan

Production capacity of Remdesivir increased to nearly 1.19 crore vials per month

Posted by: admin Categories: Covid19
Comments Off on Production capacity of Remdesivir increased to nearly 1.19 crore vials per month

Production capacity of Remdesivir increased to nearly 1.19 crore vials per month Production capacity of Remdesivir increased to nearly 1.19 crore vials per month   The Govt said that the production capacity of Remdesivir has increased to nearly 1.19 crore vials per month from 38 lakh vials per month. The Chemical and Fertilizers […]

Read more
2Jan

Bamlanivimab + Etesevimab: View Uses, Side Effects and Medicines

Posted by: admin Categories: Covid19
Comments Off on Bamlanivimab + Etesevimab: View Uses, Side Effects and Medicines

Bamlanivimab + Etesevimab Uses Bamlanivimab+Etesevimab is used in the treatment of Coronavirus disease (COVID-19). mild to moderate. How Bamlanivimab + Etesevimab works Bamlanivimab + Etesevimab is a combination of two human immunoglobulin G-1 (IgG1) neutralizing monoclonal antibodies that bind at different sites on the spike protein of SARS-CoV-2, the virus that causes Covid-19. This unique […]

Read more
1Jan

Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir

Posted by: admin Categories: Covid19
Comments Off on Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir

DOI 10.1126/science.abc1560 Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir Wanchao Yin; Chunyou Mao; Xiaodong Luan; Dan-Dan Shen; Qingya Shen; Haixia Su; Xiaoxi Wang; Fulai Zhou; Wenfeng Zhao; Minqi Gao; Shenghai Chang; Yuan-Chao Xie; Guanghui Tian; He-Wei Jiang; Sheng-Ce Tao; Jingshan Shen; Yi Jiang; Hualiang Jiang; Yechun Xu; Shuyang Zhang; […]

Read more
31Dec

COVID treatments in short supply across Connecticut, doctors say

Posted by: admin Categories: Covid19
Comments Off on COVID treatments in short supply across Connecticut, doctors say

According to Kevin Dieckhaus, chief of UConn Health’s Division of Infectious Diseases, it’s nowhere near enough. “We’re having to be very selective on who can receive monoclonal antibodies,” he said. “The demand far outpaces the supply.” The U.S. Food and Drug Administration first approved a monoclonal antibody treatment for use on COVID-19 cases last November […]

Read more
31Dec

674: Why 3 days of outpatient remdesivir is probably not going to catch on

Posted by: admin Categories: Covid19
Comments Off on 674: Why 3 days of outpatient remdesivir is probably not going to catch on

Put this image on your website to promote the show – Get embed code <a href=”” title=””><img loading=”lazy” src=”” alt=”” style=”height: 120px; max-width: 100%;” /></a> What is Listen Score? Listen Score (LS) is a metric that shows the estimated popularity of this podcast compared to other rss-based public podcasts in the world on a scale […]

Read more
30Dec

Outcomes of SOT Recipients With COVID-19 in Different Eras of COVID-19 Therapeutics

Posted by: admin Categories: Covid19
Comments Off on Outcomes of SOT Recipients With COVID-19 in Different Eras of COVID-19 Therapeutics

This article was originally published here Transplant Direct. 2021 Dec 23;8(1):e1268. doi: 10.1097/TXD.0000000000001268. eCollection 2022 Jan. ABSTRACT BACKGROUND: Few reports have focused on newer coronavirus disease 2019 (COVID-19) therapies (remdesivir, dexamethasone, and convalescent plasma) in solid organ transplant recipients; concerns had been raised regarding possible adverse impact on allograft function or secondary infections. METHODS: We […]

Read more
29Dec

Manufacturers report bamlanivimab and etesevimab meets primary endpoint in BLAZE-1 trial for use in high risk COVID-19 patients

Posted by: admin Categories: Covid19
Comments Off on Manufacturers report bamlanivimab and etesevimab meets primary endpoint in BLAZE-1 trial for use in high risk COVID-19 patients

Manufacturers report bamlanivimab and etesevimab meets primary endpoint in BLAZE-1 trial for use in high risk COVID-19 patients | Medicines Awareness Service In this study of this neutralising antibody cocktail in mild to moderate COVID-19 in high risk patients, 2.1% of patients in given treatment required hospitalisation vs 7% for control. It also reduced viral […]

Read more
28Dec

Remdesivir can be used in patients with moderate to severe COVID-19

Posted by: admin Categories: Covid19
Comments Off on Remdesivir can be used in patients with moderate to severe COVID-19

The Union Health Ministry has issued a clinical guidance for the management of the COVID-19 infection in adult patients, recommending the use of Remdesivir in patients with moderate to severe COVID-19 and those with no renal or hepatic dysfunction within 10 days of onset of any symptom. The Ministry also issued a warning against the […]

Read more
27Dec

Remdesivir to be used in patients with moderate to severe COVID infection: Govt

Posted by: admin Categories: Covid19
Comments Off on Remdesivir to be used in patients with moderate to severe COVID infection: Govt

The Centre on Friday said Remdesivir drug should only be used in patients with ‘moderate to severe’ COVID-19 and those with no renal or hepatic dysfunction within 10 days of the onset of any symptom. It also warned against use of the drug in patients who are not on oxygen support or in home settings. […]

Read more
27Dec

Products & Services | Manufacturer from Pune

Posted by: admin Categories: Covid19
Comments Off on Products & Services | Manufacturer from Pune

Packaging Size 100mg Manufacturer Hetero Brand Cipremi Treatment Covid19 Prescription/Non prescription Prescription Form Injection Country of Origin Made in India Remdesivir for injection, 100 mg, is a sterile, preservative-free lyophilized powder that is to be reconstituted with 19 mL of Sterile Water for Injection and diluted into 0.9% saline prior to administration by intravenous infusion. […]

Read more
25Dec

Remdesivir To Be Used In Patients With Moderate To Severe Covid: Centre

Posted by: admin Categories: Covid19
Comments Off on Remdesivir To Be Used In Patients With Moderate To Severe Covid: Centre

Centre stated Remdesivir drug ought to solely be utilized in sufferers with ‘reasonable to extreme’ Covid New Delhi: The Centre on Friday stated Remdesivir drug ought to solely be utilized in sufferers with ‘reasonable to extreme’ COVID-19 and people with no renal or hepatic dysfunction inside 10 days of the onset of any symptom. It […]

Read more
« Older posts
Newer posts »